Concepedia

Kevin D. Dykstra

KD

12

Publications

1.3K

Citations

12

H-Index

1999

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kevin D. Dykstra is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Drug DiscoveryMedicinePharmacologyBiochemistryNatural SciencesMedicinal ChemistryChemistryEngineeringOrganic ChemistryCatalysis

Publications per year

1999–2023

12

Publications

12

Late‐Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis

Daniel A. DiRocco, Kevin D. Dykstra, Shane W. Krska et al. · Angewandte Chemie International Edition · 2014 · 478 citations

Medicinal Chemistry, Photoredox Catalysis, Engineering +15

Chemistry informer libraries: a chemoinformatics enabled approach to evaluate and advance synthetic methods

Peter S. Kutchukian, James F. Dropinski, Kevin D. Dykstra et al. · Chemical Science · 2016 · 238 citations · Full text

Photoredox-Catalyzed Hydroxymethylation of Heteroaromatic Bases

Chelsea A. Huff, Ryan D. Cohen, Kevin D. Dykstra et al. · The Journal of Organic Chemistry · 2016 · 141 citations

Late‐Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis

Daniel A. DiRocco, Kevin D. Dykstra, Shane W. Krska et al. · Angewandte Chemie · 2014 · 118 citations

Photoredox Catalysis, Engineering, Stable Organic Peroxides +14

Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1 <i>H</i> -benzimidazole Diacylglycerol Acyltransferase 1 Inhibitors

Tim Cernak, Nathan J. Gesmundo, Kevin D. Dykstra et al. · Journal of Medicinal Chemistry · 2017 · 81 citations · Full text

Rows per page

1–5 of 12